A Convenient Synthesis of 4-Trifluoromethyl-(2H)-pyridazin-3-ones from Methyl 3,3,3-Trifluoropyruvate

Dmitriy A. Sibgatulin; Dmitriy M. Volochnyuk; Alexandr N. Kostyuk

doi:10.1055/s-2005-871926

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000083.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Synlett 2005(12): 1907-1911
DOI: 10.1055/s-2005-871926

LETTER

A Convenient Synthesis of 4-Trifluoromethyl-(2H)-pyridazin-3-ones from Methyl 3,3,3-Trifluoropyruvate

Dmitriy A. Sibgatulin, Dmitriy M. Volochnyuk, Alexandr N. Kostyuk*
Institute of Organic Chemistry, National Academy of Sciences of Ukraine, Murmanska 5, Kyiv-94, 02094, Ukraine
Fax: +380(44)5373253; e-Mail: a.kostyuk@enamine.net;

Further Information

Publication History

Received 28 April 2005
Publication Date:
07 July 2005 (online)

Abstract
Full Text
References

Permissions and Reprints All articles of this category

Abstract

A convenient two-step synthesis of 4-CF₃-(2H)-pyridazin-3-ones starting from methyl 3,3,3-trifluoropyruvate (MeTFP) and carbonyl compounds has been elaborated. As a result, a set of various 4-CF₃-(2H)-pyridazin-3-ones was obtained. The scope and limitations of the methodology is defined.

Key words

methyl 3,3,3-trifluoropyruvate - pyridazinones - trifluoromethyl - aldol condensation - cyclocondensation

References

1 Conteras J.-M. Rival YM. Chayer S. Bourguignon J.-J. Wermuth CG. J. Med. Chem. 1999, 42: 730

Crossref Google Scholar
2a Yoshinori K, Tomoyuki K, Hiromichi S, Hideo Y, Takahiro K, Shunji T, Kyoko Y, Junko T, and Seiichi S. inventors; U.S. Pat. Appl. Publ. US 2004002497. ; Chem. Abstr. 2004, 140, 77155

Article in Thieme Connect
2b Matyus P. Maes BUW. Riedl Z. Hajos G. Lemiere GLF. Tapolcsanyi P. Monsieurs K. Elias O. Dommisse RA. Krajsovszky G. Synlett 2004, 1123 ; and references therein

Article in Thieme Connect Google Scholar
3a Brule C. Bouillon J.-P. Nicolai E. Portella C. Synthesis 2003, 436

Google Scholar
3b Kamitori Y. Sekiyama T. Heterocycles 2004, 63: 707

Google Scholar
4a Fluorine in Bioorganic Chemistry Filler R. Kobayasi Y. Yagupolskii LM. Elsevier; Amsterdam: 1993.

Google Scholar
4b Hudlicky M. Chemistry of Organic Fluorine Compounds Ellis Horwood; Chichester: 1992.

Google Scholar
4c Kukhar VP. Soloshonok VA. Fluorine-Containing Amino Acids, Synthesis and Properties Wiley; New York: 1995.

Google Scholar
5a Wermuth CG. Schlewer G. Bourguignon J.-J. Maghioros G. Bouchet M.-J. Moire C. Kan J.-P. Worms P. Biziere K. J. Med. Chem. 1989, 32: 528

Article in Thieme Connect Google Scholar
5b Coates WJ. McKillop A. Synthesis 1992, 334

Article in Thieme Connect Google Scholar
5c Baraldi PG. Bigoni A. Cacciari B. Caldari C. Manfredini S. Spalluto G. Synthesis 1994, 1158

Article in Thieme Connect Google Scholar
5d Yoshida N. Awano K. Kobayashi T. Fujimori K. Synthesis 2004, 1554

Article in Thieme Connect Google Scholar
6a Golubiev AS. Galakhov MV. Kolomiets AF. Fokin AV. Izv. Akad. Nauk SSSR, Ser. Khim. 1989, 9: 2127

Article in Thieme Connect Google Scholar
6b Palecec J. Paleta O. Synthesis 2004, 521

Article in Thieme Connect Google Scholar
7 Volochnyuk DM. Kostyuk AN. Sibgatulin DA. Petrenko AE. Synthesis 2004, 2545

Article in Thieme Connect Google Scholar
8 Paleta O. Palesek J. Dolensky B. J. Fluorine Chem. 2001, 111: 175

Crossref Google Scholar
9 Zhuang W. Gathergood N. Hazell RG. Jorgensen KA. J. Org. Chem. 2001, 66: 1009

Crossref Google Scholar

10

Typical Procedure for Preparation of Compounds 7a-k.
A neat mixture of ketone 6 (1 equiv) and MeTFP (1 equiv) in a pressure tube was heated at 100 °C 1-5 h (reaction mixture was monitored by ¹⁹F NMR). After cooling the tube was opened (Caution! Excessive pressure inside!) and the residue was triturated with n-hexane yielding targeted compound 7.

11

Typical ¹H NMR data (Varian Mercury-300 spectrometer) of aldols 7.
Compound 7f: ¹H NMR (300 MHz, CDCl₃): δ = 3.59 and 3.71 (2 H, AB-syst., ² J _HH = 18.0 Hz, CH₂), 3.83 (3 H, s, OCH₃), 4.18 (1 H, br s, OH), 7.48 (1 H, dd, ³ J _HH = 7.8 Hz, ³ J _HH = 4.8 Hz, CH), 8.13 (1 H, dt, ³ J _HH = 7.8 Hz, ⁴ J _HH = 2.5 Hz, CH), 8.72 (1 H, dd, ³ J _HH = 4.8 Hz, ⁴ J _HH = 2.5 Hz, CH), 9.07 (1 H, d, ⁴ J _HH = 2.5 Hz, CH).
Compound 7g: ¹H NMR (300 MHz, DMSO-d ₆): δ = 3.77 (3 H, s, OCH₃), 3.83 (2 H, s, CH₂), 7.05, (1 H, s, OH), 7.87 (2 H, d, ³ J _HH = 6.0 Hz, CH), 8.20 (2 H, d, ³ J _HH = 6.0 Hz, CH).
Compound 7i: ¹H NMR (300 MHz, CDCl₃): δ = 3.64 and 3.70 (2 H, AB-syst., ² J _HH = 17.1 Hz, CH₂), 3.93 (3 H, s, OCH₃), 4.24 (1 H, br s, OH), 7.17 (1 H, t, ³ J _HH = 4.8 Hz, CH), 7.72 (1 H, d, ³ J _HH = 4.8 Hz, CH), 7.76 (1 H, d, ³ J _HH = 4.8 Hz, CH).

12

Typical ¹³C NMR data (Varian Mercury-400 spectrometer) of aldols 7.
Compound 7f: ¹³C NMR (100 MHz, CDCl₃): δ = 41.0, 54.2, 74.9 (CCF₃, ² J _CF = 32.9 Hz), 123.1 (CF₃, ¹ J _CF = 285.1 Hz), 123.8, 128.3, 131.2, 135.5, 149.4, 154.1, 169.1, 193.6.
Compound 7g: ¹³C NMR (100 MHz, DMSO-d ₆): δ = 42.1, 53.2, 73.2 (CCF₃, ² J _CF = 28.2 Hz), 121.3, 123.7 (CF₃, ¹ J _CF = 285.7 Hz), 141.8, 151.0, 168.5, 195.2.
Compound 7i: ¹³C NMR (100 MHz, CDCl₃): δ = 41.0, 54.2, 75.2 (CCF₃, ² J _CF = 29.5 Hz), 122.1 (CF₃, ¹ J _CF = 285.3 Hz), 128.4, 133.1, 135.1, 142.7, 169.2, 187.4.

13

Typical MS data (MX-1321 instrument) of aldols 7.
Compound 7f: MS (EI, 70 eV): m/z (%) = 277 (4) [M⁺], 218 (26) [M⁺ - CO₂Me], 106 (100) [3-pyridyl - CO⁺], 78 (40) [3-pyridyl⁺], 51 (17).
Compound 7g: MS (EI, 70 eV): m/z (%) = 277 (5) [M⁺], 218 (27) [M⁺ - CO₂Me], 106 (100) [4-pyridyl - CO⁺], 78 (42) [4-pyridyl⁺], 51 (21).
Compound 7i: MS (EI, 70 eV): m/z (%) = 282 (4) [M⁺], 223 (15) [M⁺ - CO₂Me], 111 (100) [2-thienyl - CO⁺], 39 (16).

14

Typical Procedure for Preparation of (2 H )-Pyridazine-3-ones 8. To a solution of aldol 7 (1 equiv) in HOAc (5 mL) NH₂NH₂·H₂O (3 equiv) was added. The reaction mixture was refluxed for 1 h. After cooling the solvent was evaporated in vacuum and the residue was triturated with H₂O affording 8.

15

Typical ¹H NMR data (Varian Mercury-300 spectrometer) of 4-trifluoromethyl-(2H)-pyridazine-3-ones 8.
Compound 8f: ¹H NMR (300 MHz, DMSO-d ₆): δ = 7.54 (1 H, t, ³ J _HH = 7.2 Hz, CH), 8.31 (1 H, d, ³ J _HH = 7.2 Hz, CH), 8.51 (1 H, s, CH), 8.66 (1 H, d, ³ J _HH = 3.6 Hz, CH), 9.12 (1 H, s, CH), 13.97 (1 H, br s, NH).
Compound 8g: ¹H NMR (300 MHz, DMSO-d ₆): δ = 8.52 (2 H, d, ³ J _HH = 6.3 Hz, CH), 9.10 (1 H, s, CH), 9.29 (2 H, d, ³ J _HH = 6.3 Hz, CH).
Compound 8i: ¹H NMR (300 MHz, DMSO-d ₆): δ = 7.18 (1 H, s, CH), 7.69 (1 H, s, CH), 7.91 (1 H, s, CH), 8.47 (1 H, s, CH), 13.73 (1 H, s, NH).

16

Typical ¹³C NMR data (Varian Mercury-400 spectrometer) of 4-trifluoromethyl-(2H)-pyridazine-3-ones 8.
Compound 8f: ¹³C NMR (100 MHz, DMSO-d ₆): δ = 121.6 (CF₃, ¹ J _CF = 271.8 Hz), 123.8, 127.6 (CCF₃, ² J _CF = 31.9 Hz), 129.7, 130.4 (CCCF₃, ³ J _CF = 5.0 Hz), 133.6, 141.6, 147.1, 150.3, 156.1.
Compound 8g: ¹³C NMR (100 MHz, DMSO-d ₆): δ = 119.9, 121.5 (CF₃, ¹ J _CF = 270.9 Hz), 127.6 (CCF₃, ² J _CF = 31.6 Hz), 129.9 (CCCF₃, ³ J _CF = 4.9 Hz), 140.9, 141.2, 150.3, 156.3, 172.0.
Compound 8i: ¹³C NMR (100 MHz, DMSO-d ₆): δ = 121.3 (CF₃, ¹ J _CF = 271.4 Hz), 127.8, 127.9 (CCF₃, ² J _CF = 31.2 Hz), 128.4, 128.9, 129.5 (CCCF₃, ³ J _CF = 4.9 Hz), 138.3, 140.3, 156.0.

17

Typical MS data (MX-1321 instrument) of 4-trifluoromethyl-(2H)-pyridazine-3-ones 8.
Compound 8f: MS (EI, 70 eV): m/z (%) = 242 (9) [M + 1], 241 (100) [M⁺], 184 (37).
Compound 8g: MS (EI, 70 eV): m/z (%) = 242 (10) [M + 1], 241 (100) [M⁺], 184 (24).
Compound 8i: MS (EI, 70 eV): m/z (%) = 247 (9) [M + 1], 246 (100) [M⁺], 189 (54).

18

Procedure for Preparation of 1,6-Dihydro-6-oxo-5-(trifluoromethyl)-3-pyridazineacetonitrile ( 10). To a solution of aldol 9a (1 g, 4.2 mmol) in HOAc (10 mL) NH₂NH₂·H₂O (0.63 g, 12.6 mmol) was added. The reaction mixture was refluxed for 3 h (reaction mixture was monitored by ¹⁹F NMR). After cooling the solvent was evaporated in vacuum and the residue was triturated with H₂O and extracted with Et₂O (10 mL). The Et₂O was evaporated in vacuum affording 10 (0.68 mg, 81%). Mp 175 °C. ¹H NMR (300 MHz, DMSO-d ₆): δ = 4.15 (2 H, s, CH₂), 7.93 (1 H, s, CH), 13.8 (1 H, br s, NH). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 23.1, 117.1, 121.4 (CF₃, ¹ J _CF = 270.8 Hz), 127.8 (CCF₃, ² J _CF = 31.2 Hz), 132.8, 139.1, 156.5. MS (EI, 70 eV): m/z (%) = 204 (100) [M⁺], 148 (15), 120 (39), 106 (14), 75 (19).

19

Procedure for Preparation of Methyl α-Hydroxy-5-phenyl-α-(trifluoromethyl)-1 H -pyrazole-3-propanoate ( 11). To a solution of aldol 9b (1 g, 3.1 mmol) in HOAc (10 mL) NH₂NH₂·H₂O (0.47g, 9.3 mmol) was added. The reaction mixture was refluxed for 1 h (reaction mixture was monitored by ¹⁹F NMR). After cooling the solvent was evaporated in vacuum and the residue was triturated with H₂O affording 11 (0.83 mg, 84%). Mp 98 °C. ¹H NMR (300 MHz, DMSO-d ₆): δ = 3.11 and 3.33 (2 H, AB-syst., ² J _HH = 14.1 Hz, CH₂), 3.76 (3 H, s, OCH₃), 6.46 (1 H, s, CH), 7.04 (1 H, br s, OH), 7.32-7.41 (3 H, m, CH), 7.72 (2 H, d, ³ J _HH = 6.3 Hz, CH), 12.94 (1 H, br s, NH). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 31.2 (br, Δν_1/2 ca. 30 Hz), 53.7, 78.1 (CCF₃, ² J _CF = 27.7 Hz), 102.9, 124.6 (CF₃, ¹ J _CF = 288.0 Hz), 125.4, 128.1, 129.3, 132.0 (br, Δν_1/2 ca. 65 Hz), 141.2 (br, Δν_1/2 ca. 300 Hz), 146.6 (br, Δν_1/2 ca. 270 Hz), 168.6. MS (EI, 70 eV): m/z (%) = 314 (38) [M⁺], 255 (40) [M⁺ - CO₂Me], 157 (100) [M⁺ - MeTFP].

20

Procedure for Preparation of Ethyl 1,6-Dihydro-6-oxo-5-(trifluoromethyl)-3-pyridazineacetate ( 12) and Methyl α,5-Dihydroxy-α-(trifluoromethyl)-1 H -pyrazole-3-propanoate ( 13).
To a solution of aldol 9c (1 g, 3.5 mmol) in HOAc (10 mL) NH₂NH₂·H₂O (0.53 g, 10.5 mmol) was added. The reaction mixture was refluxed for 1 h (reaction was monitored by ¹⁹F NMR). After cooling the solvent was evaporated in vacuum and the residue was triturated with Et₂O. The solvent was evaporated and the residue was dissolved in CH₂Cl₂ (10 mL). The insoluble precipitate was filtered affording 13 (0.43 g, 48%). The mother liquid was evaporated and the residue was triturated with hexane giving 12 (0.41 g, 47%).
Compound 12: mp 87 °C. ¹H NMR (300 MHz, CDCl₃): δ = 1.3 (3 H, t, ³ J _HH = 7.2 Hz, CH₃), 3.75 (2 H, s, CH₂), 7.71 (1 H, s, CH), 10.02 (1 H, br s, NH). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 14.4, 20.9, 39.5, 53.6, 61.3, 120.1 (CF₃, ¹ J _CF = 272.9 Hz), 127.3 (CCF₃, ² J _CF = 31.4 Hz), 133.9, 141.8, 156.5, 168.4, 170.0. MS (EI, 70 eV): m/z (%) = 250 (35) [M⁺], 178 (86) [M⁺ - CO₂Et], 158 (40), 120 (20), 101 (49), 97 (33), 75 (20), 74 (43), 69 (24) [CF₃], 51 (25), 43 (100).
Compound 13: mp 196 °C ¹H NMR (300 MHz, DMSO-d ₆): δ = 2.94 and 3.16 (2 H, AB-syst., ² J _HH = 14.4 Hz, CH₂), 3.73 (3 H, s, OCH₃), 5.24 (1 H, s, CH), 7.0 (1 H, br s, OH), 10.6 (1 H, br s, NH). ¹³C NMR (100 MHz, DMSO-d ₆): δ = 30.8, 53.6, 77.8 (CCF₃, ² J _CF = 27.5 Hz), 89.8, 124.4 (CF₃, J _CF = 285.6 Hz), 137.3, 160.5, 168.4. MS (EI, 70 eV): m/z (%) = 254 (10) [M⁺], 195 (10) [M⁺ - CO₂Me], 98 (100) [M⁺ - MeTFP].